DigiNepal Health ENनेहि

← स्वास्थ्य · औषधि

Beractant

Surfactant

WHO अत्यावश्यक औषधि EML खण्ड: Medicines administered to the neonate

यो जानकारी मात्र हो, प्रिस्क्रिप्सन होइन। कुनै पनि औषधि लिनुअघि डाक्टर वा फार्मासिस्टसँग सल्लाह लिनुहोस्। ओभरडोज वा विषाक्तता भए १०२ मा फोन गर्नुहोस्।

ब्रान्ड नाम

Nepal brand names not included: no licence-safe source.

What it is used for

SURVANTA is indicated for prevention and treatment (“rescue”) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants.

Common side effects

The occurrence of concurrent illnesses common in premature infants was evaluated in the controlled trials. The rates in all controlled studies are in Table 3. Table 3.

Do not use if (contraindications)

None

ओभरडोज वा विषाक्तता

ओभरडोज वा विषाक्तता शंका भए अहिले नै १०२ मा फोन गर्नुहोस्।

१०२

सामान्य प्रश्न

What is Beractant used for?
SURVANTA is indicated for prevention and treatment (“rescue”) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants.

What are the side effects of Beractant?
The occurrence of concurrent illnesses common in premature infants was evaluated in the controlled trials. The rates in all controlled studies are in Table 3. Table 3.

Who should not take Beractant?
None

What is the dose of Beractant?
Not provided here. Ask a doctor or pharmacist.

Beractant के हो?
Beractant is used for: SURVANTA is indicated for prevention and treatment (“rescue”) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants. It belongs to the class: Surfactant. Common side effects include: The occurrence of concurrent illnesses common in premature infants was evaluat…

Beractant का साइड इफेक्ट के हुन्?
The occurrence of concurrent illnesses common in premature infants was evaluated in the controlled trials. The rates in all controlled studies are in Table 3. Table 3.

स्रोत: FDA SPL label (openFDA/DailyMed); RxNorm (NLM) · Reference · Reference · Reference

US FDA DailyMed; NLM RxNorm

आपत्काल — फोन102